Table A4:

Multinomial logistic regression results: person-year adjusted odds ratios of receiving MOUD and psychosocial visits, MOUD but no psychosocial visits, or psychosocial visits but no MOUD vs. receiving neither MOUD nor psychosocial visits among commercially insured health plan enrollees with OUD, 2008–2016 (N= 87,877 persons and 122,708 person-years).

	MOUD & psychosocial visits		MOUD but no psychosocial visits		Psychosocial visits but no MOUD
	AOR	95%CI	AOR	95%CI	AOR	95%CI
Age (ref=55–64)
17–24	3.90	3.46–4.40	1.65	1.54–1.76	3.67	3.30–4.08
25–34	4.34	3.87–4.87	2.65	2.50–2.82	3.10	2.79–3.44
35–44	2.68	2.37–3.02	2.06	1.93–2.19	1.92	1.71–2.14
45–54	1.60	1.41–1.81	1.41	1.33–1.50	1.34	1.20–1.50
Male	1.39	1.31–1.48	1.41	1.36–1.46	1.26	1.20–1.33
Employee	.98	.92–1.05	1.07	1.03–1.11	.88	.83–.93
Region (ref=South)
Northeast	2.27	2.12–2.43	1.18	1.13–1.23	2.14	2.01–2.28
Midwest	2.07	1.89–2.27	1.13	1.06–1.20	2.05	1.88–2.24
West	1.00	.92–1.09	.95	.91–1.00	1.12	1.04–1.22
Rural	1.03	.91–1.17	.98	.90–1.06	1.00	.88–1.13
Comorbid substance use disorder	1.30	1.23–1.37	.89	.86–.92	2.05	1.94–2.17
Comorbid mental health condition	1.23	1.16–1.30	1.14	1.10–1.18	1.30	1.23–1.37
Moderate/severe OUD	16.16	12.66–20.63	2.60	2.43–2.78	2.33	2.09–2.60
OUD overdose	.32	.28–.36	.30	.28–.33	.33	.29–.37
Year (ref=2008)
2009	1.47	1.28–1.69	1.56	1.47–1.66	.91	.80–1.03
2010	2.04	1.78–2.35	2.11	1.98–2.25	.87	.76–.99
2011	1.97	1.71–2.27	2.11	1.98–2.25	.97	.85–1.10
2012	1.67	1.45–1.92	1.63	1.53–1.74	.85	.75–.96
2013	4.61	4.06–5.24	1.49	1.39–1.59	2.29	2.05–2.56
2014	4.04	3.55–4.58	1.19	1.12–1.27	2.32	2.08–2.59
2015	3.72	3.27–4.22	1.02	.96–1.09	2.07	1.86–2.31
2016	3.53	3.11–4.01	.93	.87–.99	2.11	1.89–2.35

Note: Reference category = neither OUD medications nor OUD psychosocial visits. There has been no adjustment for multiplicity.